AAAAAA
Results: 1-25/41
Authors:
MURRAY MD
TIERNEY WM
BRATER DC
Citation: Md. Murray et al., DETERMINING THE EFFECTIVENESS OF TORASEMIDE AND FUROSEMIDE IN HEART-FAILURE - DESIGN OF A RANDOMIZED COMPARISON USING THE REGENSTRIEF-MEDICAL-RECORD-SYSTEM, Clinical drug investigation, 16(1), 1998, pp. 45-52
Authors:
RUDY AC
LIU YX
BRATER DC
HALL SD
Citation: Ac. Rudy et al., STEREOSELECTIVE PHARMACOKINETICS AND INVERSION OF (R)-KETOPROFEN IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 38(2), 1998, pp. 3-10
Authors:
BRATER DC
Citation: Dc. Brater, DIURETIC THERAPY, The New England journal of medicine, 339(6), 1998, pp. 387-395
Authors:
AZIE NE
BRATER DC
BECKER PA
JONES DR
HALL SD
Citation: Ne. Azie et al., THE INTERACTION OF DILTIAZEM WITH LOVASTATIN AND PRAVASTATIN, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 369-377
Authors:
STRONG ML
GORSKI JC
RUDY AC
BRATER DC
HALL SD
Citation: Ml. Strong et al., EFFECT OF KETOPROFEN ON THE RENAL EXCRETION OF SODIUM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 100-100
Authors:
BENNETT SJ
HUSTER GA
MURRAY MD
ADAMS LD
FORTHOFER MM
FERGUSON JA
TIERNEY WM
BRATER DC
Citation: Sj. Bennett et al., SOCIAL SUPPORT IN INNER-CITY HEART-FAILURE PATIENTS, Circulation, 98(17), 1998, pp. 325-325
Authors:
MURRAY MD
HAAG KM
BLACK PK
HALL SD
BRATER DC
Citation: Md. Murray et al., VARIABLE FUROSEMIDE ABSORPTION AND POOR PREDICTABILITY OF RESPONSE INELDERLY PATIENTS, Pharmacotherapy, 17(1), 1997, pp. 98-106
Authors:
FERGUSON JA
SUNDBLAD KJ
BECKER PK
GORSKI JC
RUDY DW
BRATER DC
Citation: Ja. Ferguson et al., ROLE OF DURATION OF DIURETIC EFFECT IN PREVENTING SODIUM RETENTION, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 203-208
Authors:
AGBIM NE
BRATER DC
HALL SD
Citation: Ne. Agbim et al., INTERACTION OF DILTIAZEM WITH LOVASTATIN AND PRAVASTATIN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 29-29
Authors:
MAYA JF
CALLAGHAN JT
BERGSTROM RF
CERIMELE BJ
KASSAHUN K
NYHART EH
BRATER DC
Citation: Jf. Maya et al., OLANZAPINE AND WARFARIN DRUG-INTERACTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 67-67
Authors:
MURRAY MD
LAZARIDIS EN
BRIZENDINE E
HAAG K
BECKER P
BRATER DC
Citation: Md. Murray et al., THE EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON ELECTROLYTE HOMEOSTASIS AND BLOOD-PRESSURE IN YOUNG AND ELDERLY PERSONS WITH AND WITHOUT RENAL-INSUFFICIENCY, The American journal of the medical sciences, 314(2), 1997, pp. 80-88
Authors:
BRATER DC
GOLDMAN L
KLEMPNER M
KOKKO J
Citation: Dc. Brater et al., CREATING SOLUTIONS TO MEET THE CHALLENGES FACING BIOMEDICAL-RESEARCH - REPORT OF THE 1996 APM-FALL-SYMPOSIUM, The American journal of medicine, 102(2), 1997, pp. 133-140
Authors:
VARGO DL
BRATER DC
RUDY DW
SWAN SK
Citation: Dl. Vargo et al., DOPAMINE DOES NOT ENHANCE FUROSEMIDE-INDUCED NATRIURESIS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of the American Society of Nephrology, 7(7), 1996, pp. 1032-1037
Authors:
BRATER DC
Citation: Dc. Brater, BENEFITS AND RISKS OF TORASEMIDE IN CONGESTIVE-HEART-FAILURE AND ESSENTIAL-HYPERTENSION, Drug safety, 14(2), 1996, pp. 104-120
Authors:
KRAMER WG
SMITH WB
FERGUSON J
SERPAS T
GRANT AG
BLACK PK
BRATER DC
Citation: Wg. Kramer et al., PHARMACODYNAMICS OF TORSEMIDE ADMINISTERED AS AN INTRAVENOUS-INJECTION AND AS A CONTINUOUS-INFUSION TO PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 36(3), 1996, pp. 265-270
Authors:
WOLFF AA
BRATER DC
SPANYERS S
BELARDINELLI L
SCHREINER GF
Citation: Aa. Wolff et al., CVT-124, A NOVEL AND SELECTIVE ADENOSINE-A1 ANTAGONIST, IS A DIURETICIN MAN WITH BOTH PROXIMAL AND DISTAL TUBULAR SITES OF ACTION, Circulation, 94(8), 1996, pp. 547-547
Authors:
SWAN SK
VARGO DL
RUDY DL
BRATER DC
Citation: Sk. Swan et al., DOPAMINE (DA) DOES NOT ENHANCE FUROSEMIDE (F)-INDUCED NATRIURESIS IN PATIENTS WITH COMPENSATED CONGESTIVE-HEART-FAILURE (CHF), Journal of the American Society of Nephrology, 6(3), 1995, pp. 477-477
Authors:
BRATER DC
Citation: Dc. Brater, ARE THERE ANY OBJECTIVE MEASUREMENTS OF THE POTENCY OF DIURETICS - IFSO, HOW MUCH DOES ADDING 5-MG AMILORIDE TO 40-MG FRUSEMIDE INCREASE THE POTENCY, BMJ. British medical journal, 310(6971), 1995, pp. 30-30
Authors:
RUDY AC
KNIGHT PM
BRATER DC
HALL SD
Citation: Ac. Rudy et al., ENANTIOSELECTIVE DISPOSITION OF IBUPROFEN IN ELDERLY PERSONS WITH ANDWITHOUT RENAL IMPAIRMENT, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 88-93
Authors:
VARGO DL
KRAMER WG
BLACK PK
SMITH WB
SERPAS T
BRATER DC
Citation: Dl. Vargo et al., BIOAVAILABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TORSEMIDE AND FUROSEMIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 601-609
Authors:
VARGO DL
KRAMER WG
BRATER DC
Citation: Dl. Vargo et al., BIOAVAILABILITY, PK AND PD OF TORSEMIDE AND FUROSEMIDE IN CHF PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 141-141
Authors:
JOHNSON JL
BRATER DC
HALL SD
Citation: Jl. Johnson et al., FORMATION OF HYBRID GLYCEROLIPIDS IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213
Authors:
MURRAY MD
BLACK PK
KUZMIK DD
HAAG KM
MANATUNGA AK
MULLIN MA
HALL SD
BRATER DC
Citation: Md. Murray et al., ACUTE AND CHRONIC EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON GLOMERULAR-FILTRATION RATE IN ELDERLY PATIENTS, The American journal of the medical sciences, 310(5), 1995, pp. 188-197
Authors:
TRACY TS
WORSTER T
BRADLEY JD
GREENE PK
BRATER DC
Citation: Ts. Tracy et al., METHOTREXATE DISPOSITION FOLLOWING CONCOMITANT ADMINISTRATION OF KETOPROFEN, PIROXICAM AND FLURBIPROFEN IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of clinical pharmacology, 37(5), 1994, pp. 453-456
Authors:
RUDY AC
FIGUEROA NL
HALL SD
BRATER DC
Citation: Ac. Rudy et al., THE PHARMACOKINETICS OF PIROXICAM IN ELDERLY PERSONS WITH AND WITHOUTRENAL IMPAIRMENT, British journal of clinical pharmacology, 37(1), 1994, pp. 1-5